Zozaya-Valdés, Enrique
Wong, Stephen Q.
Raleigh, Jeanette
Hatzimihalis, Athena
Ftouni, Sarah
Papenfuss, Anthony T.
Sandhu, Shahneen
Dawson, Mark A.
Dawson, Sarah-Jane https://orcid.org/0000-0002-8276-0374
Funding for this research was provided by:
National Health and Medical Research Council (1107126)
National Health and Medical Research Council (1196755)
National Health and Medical Research Council (1196749)
National Health and Medical Research Council (1194783)
National Health and Medical Research Council (1116955)
Cancer Council Victoria
Victorian Cancer Agency
Howard Hughes Medical Institute (55008729)
Article History
Received: 1 October 2020
Accepted: 4 June 2021
First Online: 23 June 2021
Declarations
:
: Written informed consent was obtained from all patients under an approved Human Research Ethics Committee protocol from the Peter MacCallum Cancer Centre (PMCC: 11/105) with all methods performed in accordance with the Helsinki Declaration and relevant ethical guidelines and regulations of the Australian National Health and Medical Research Council.
: Not applicable.
: S.J.D has been a member of an advisory board for Astra Zeneca and Inivata. S.J.D has received research funding from Genentech. S.J.D and M.A.D have received research funding from CTx CRC. M.A.D. has been a member of advisory boards for CTx CRC, Storm Therapeutics, Celgene and Cambridge Epigenetix.